Catalyst Pharmaceuticals Inc Earnings

Catalyst Pharmaceuticals Inc’s revenue jumped 19.44% since last year same period to $146.56Mn in the Q2 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 3.64% jump in its revenue since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit jumped 27.73% since last year same period to $52.11Mn in the Q2 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated -8.16% fall in its net profits since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit margin jumped 6.95% since last year same period to 35.55% in the Q2 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated -11.38% fall in its net profit margins since last 3-months.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.36 - a -7.69% fall from last quarter’s estimates.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.36.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Catalyst Pharmaceuticals Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.